- Home
- NERV vs WETH Comparison
NERV vs WETH Comparison
Compare NERV & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- WETH
- Stock Information
- Founded
- NERV 2007
- WETH 1992
- Country
- NERV United States
- WETH China
- Employees
- NERV N/A
- WETH N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- WETH
- Sector
- NERV Health Care
- WETH
- Exchange
- NERV Nasdaq
- WETH Nasdaq
- Market Cap
- NERV 12.0M
- WETH 10.9M
- IPO Year
- NERV 2014
- WETH N/A
- Fundamental
- Price
- NERV $2.25
- WETH $0.89
- Analyst Decision
- NERV Hold
- WETH
- Analyst Count
- NERV 1
- WETH 0
- Target Price
- NERV $5.00
- WETH N/A
- AVG Volume (30 Days)
- NERV 35.1K
- WETH 82.7K
- Earning Date
- NERV 08-14-2025
- WETH 08-26-2025
- Dividend Yield
- NERV N/A
- WETH N/A
- EPS Growth
- NERV N/A
- WETH N/A
- EPS
- NERV 1.48
- WETH 0.34
- Revenue
- NERV N/A
- WETH $41,024,264.00
- Revenue This Year
- NERV N/A
- WETH N/A
- Revenue Next Year
- NERV N/A
- WETH N/A
- P/E Ratio
- NERV $1.52
- WETH $2.59
- Revenue Growth
- NERV N/A
- WETH 2.86
- 52 Week Low
- NERV $1.15
- WETH $0.76
- 52 Week High
- NERV $3.00
- WETH $2.96
- Technical
- Relative Strength Index (RSI)
- NERV 69.92
- WETH 50.72
- Support Level
- NERV $1.79
- WETH $0.79
- Resistance Level
- NERV $1.81
- WETH $0.89
- Average True Range (ATR)
- NERV 0.10
- WETH 0.06
- MACD
- NERV 0.01
- WETH 0.01
- Stochastic Oscillator
- NERV 76.56
- WETH 57.39
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.